Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT03921957
Eligibility Criteria:
Inclusion Criteria:
* Histologic or cytologic diagnosis of non small cell lung cancer stage IA-IB (T1N0M0 or T2aN0M0)
* None histologic or cytologic diagnosis of non small cell lung cancer stage IA-IB (T1N0M0 or T2aN0M0) with evolutionary criteria (increase on two successive CT scan and pathological hyperfixation in the TEP scan)
* Resectable tumor but patient unfit for surgical resection
* Resectable tumor but patient refusing surgical resection
* KPS \> 60%
* Pulmonary functions: FEV \> 40% theoric value, PO2 ≥ 70mmHg, PCO2 \< 50mmHg
* Patient who can hold appropriate immobilization in dorsal decubitus during approximately 30 minutes
* Age 18 years or older
* Not affected by a mental disease
* Understanding and be informed of the investigational nature of this study and must give written consent prior to the receiving of treatment per this protocol
* Inscription at the French Social Security
Exclusion Criteria:
* Patient pregnant
* Patient deprived of freedom or under guardianship
* Pulmonary functions : FEV \< 40% theoric value, PO2 ≤ 70mmHg, PCO2 \> 50mmHg
* Prior thoracic radiation treatment
* Prior radiation pneumonitis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03921957
Study Brief:
Protocol Section:
NCT03921957